Medscape April 18, 2024
Colorectal cancer (CRC) is a major public health issue, with over 43,000 new cases and nearly 17,700 deaths annually in France. The overall survival rate is currently 63%. It is much higher for early stages than for advanced stages. Screening allows for the diagnosis of the disease in its early stages, when it is responsive to curative treatment, thus reducing specific CRC mortality.
The screening methods currently depend on the risk level of developing CRC, as defined by the Health Authority. Apart from patients at high risk for CRC (eg, those with a personal and family history of polyps or CRC, chronic inflammatory bowel disease, and genetic polyposis), patients aged 50-74 years with average risk are now invited every 2...
Today's Sponsors
Today's Sponsor